Celecoxib Shown Safer Than NSAIDs in Osteoarthritis : The COX-2 inhibitor was as effective as naproxen and diclofenac, while causing fewer upper GI events.

Dr. Singh disclosed that he received research support from Searle Pharmaceuticals, Pharmacia, Pfizer, Merck & Co., Boehringer Ingelheim, TAP Pharmaceuticals, Wyeth, Altana Pharma, GlaxoSmithKline, Novartis Pharmaceuticals Corp., and Centocor Inc.

The finding 'shows conclusively that celecoxib does reduce the risk of upper GI complications.' DR. SINGH